Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Verastem in a ...